HSP70i

Loyola University of Chicago researchers have developed a genetically modified protein with potential in reversing the effects of vitiligo in mice.

The group of researchers led by Dr. Caroline Le Poole described their findings in an article published in  "Science Translational Medicine"

Previous studies performed by this group of researchers have shown that the HSP70i protein plays a vital role in the autoimmune response that causes vitiligo.